Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booking.com
BKNG
|
+$566M |
| 2 |
Meta Platforms (Facebook)
META
|
+$401M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
+$366M |
| 4 |
Align Technology
ALGN
|
+$356M |
| 5 |
PayPal
PYPL
|
+$278M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$564M |
| 2 |
Alibaba
BABA
|
+$511M |
| 3 |
Altria Group
MO
|
+$439M |
| 4 |
Revvity
RVTY
|
+$321M |
| 5 |
Merck
MRK
|
+$316M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.77% |
| 2 | Healthcare | 19.73% |
| 3 | Consumer Discretionary | 11.5% |
| 4 | Financials | 9.61% |
| 5 | Communication Services | 8.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
W.W. Grainger
GWW
$64.2B
| $66.2M | 0.03% |
185,424
-25,447
| -12% | -$8.77M |
|
427
Ambarella
AMBA
$3.04B
| $65.6M | 0.03% |
1,257,364
+395,908
| +46% | +$19.1M |
|
428
Sonoco
SON
$5.83B
| $65.5M | 0.03% |
1,283,447
-35,432
| -3% | -$1.88M |
|
429
AT&T
T
$164B
| $65.2M | 0.03% |
3,029,487
-333,409
| -10% | -$7.45M |
|
430
Azenta
AZTA
$1.3B
| $65.2M | 0.03% |
1,409,278
+671,951
| +91% | +$32.5M |
|
431
Colgate-Palmolive
CL
$74.8B
| $64.8M | 0.03% |
839,621
+297,765
| +55% | +$22.7M |
|
432
Omnicom Group
OMC
$22.7B
| $64.7M | 0.03% |
1,307,714
+42,848
| +3% | +$2.29M |
|
433
Chevron
CVX
$382B
| $64.5M | 0.03% |
896,042
+16,266
| +2% | +$1.37M |
|
|
DRE
434
DELISTED
Duke Realty Corp.
DRE
| $64.4M | 0.03% |
1,744,520
-46,975
| -3% | -$1.77M |
|
435
Maximus
MMS
$3.32B
| $64.3M | 0.03% |
940,187
-5,304
| -0.6% | -$390K |
|
436
Alexandria Real Estate Equities
ARE
$9.37B
| $64.1M | 0.03% |
401,142
-15,529
| -4% | -$2.59M |
|
437
argenx
ARGX
$55.2B
| $63.8M | 0.03% |
242,964
-53,683
| -18% | -$12.9M |
|
438
Encompass Health
EHC
$11.3B
| $63.7M | 0.03% |
1,231,703
+221,687
| +22% | +$11.4M |
|
439
BridgeBio Pharma
BBIO
$16.4B
| $63.5M | 0.03% |
1,691,461
-74,403
| -4% | -$2.34M |
|
440
Natera
NTRA
$36.4B
| $62.9M | 0.03% |
+870,497
| New | +$49.5M |
|
|
IGMS
441
DELISTED
IGM Biosciences
IGMS
| $62.4M | 0.03% |
844,935
-82,415
| -9% | -$4.88M |
|
442
Invitation Homes
INVH
$17.9B
| $62.1M | 0.03% |
2,220,738
+88,597
| +4% | +$2.53M |
|
443
Healthpeak Properties
DOC
$15.5B
| $62M | 0.03% |
2,282,422
+333,305
| +17% | +$9.13M |
|
444
M&T Bank
MTB
$36.3B
| $62M | 0.03% |
672,760
-23,846
| -3% | -$2.44M |
|
445
QuidelOrtho
QDEL
$1.13B
| $61.6M | 0.03% |
280,743
-49,458
| -15% | -$11M |
|
446
Emcor
EME
$29.9B
| $61.3M | 0.03% |
904,891
+895,991
| +10,067% | +$62.2M |
|
447
Atlantic Union Bankshares
AUB
$6.05B
| $60.2M | 0.03% |
2,814,947
-7,764
| -0.3% | -$177K |
|
448
J.M. Smucker
SJM
$13.5B
| $60.1M | 0.03% |
519,898
-1,757
| -0.3% | -$196K |
|
449
Fox Class B
FOX
$22.1B
| $59.7M | 0.03% |
2,132,991
-535,918
| -20% | -$14.2M |
|
|
GRFS
450
Grifois
GRFS
$5.55B
| $59.5M | 0.03% |
3,427,369
-22,597
| -0.7% | -$399K |
|
Similar funds
Janus Henderson Group's Q3 2020 Portfolio in Review
As of Q3 2020, Janus Henderson Group held 1,403 positions worth $192B, up 7.7% from $178B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Janus Henderson Group's Q3 2020 filing shows 105 new, 521 increased, 678 reduced and 86 closed positions. Its largest new stake was Acceleron Pharma: 1,783,939 shares worth $201M. The largest sale was Apple, an estimated $564M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q3 2020 buy was Acceleron Pharma: 1,783,939 shares worth $201M.
- Janus Henderson Group added most to Booking.com in Q3 2020, an estimated $566M increase.
- Janus Henderson Group's biggest Q3 2020 reduction was Apple, cutting an estimated $564M.
- Janus Henderson Group fully exited Momenta Pharmaceuticals, Inc. in Q3 2020, selling an estimated $49.5M.
- Janus Henderson Group's ten largest holdings make up 24% of its $192B portfolio in Q3 2020.
- Janus Henderson Group opened 105 new positions and closed 86 in Q3 2020.
- Janus Henderson Group's portfolio value rose 7.7% quarter-over-quarter to $192B.
Based on Janus Henderson Group's 13F filing for Q3 2020, filed 16 Nov 2020.